Sanofi-Aventis SA : Chattem Inc Dealogic Deal #  : 660927
Data as of : 12/21/2009
Target Acquiror Dates & Values
Chattem Inc Sanofi-Aventis SA
Target: 100 % stake Buying: 100 % stake Rumored - Deal Value $m 2,196.9
Nasdaq CHTT 19 m shares outstanding Public (Listed) Announced 21st Dec 2009 Value ex Debt $m 1,856.3
United States France
Healthcare Healthcare Expected 21st Feb 2010 Consideration
Morgan Stanley | Advisor Goldman Sachs | Advisor Completed -
Skadden Arps | Attorney Weil, Gotshal & Manges | Attorney
Withdrawn -
Termination Fee, Target $m tbd
Termination Fee, Acquiror $m tbd
Financials 31st Aug 2009
Balance Sheet Debt/Equity: 1.5
Timeline Events Premiums & Multiples
Initial Offer $93.50
Current Offer $93.50
Income Statement
Cash Flows
Operations $m 99
Profitability
Profit Margin 28%
Return on Equity 25%
League Table Impact Sector Trend
2009 YTD Announced Global M&A by Deal Value, $bn Monthly Announced Global M&A, $bn: Healthcare
1 Goldman Sachs 626.1
2 Morgan Stanley 604.5
3 JPMorgan 585.2
4 Citi 438.8
5 BAML 383.4
6 Credit Suisse 333.5
7 UBS 318.9
8 Barclays Capital 296.4
9 Lazard 280.1
10 Deutsche Bank 278.7
© 2009 Dealogic.  All rights reserved.